CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,321,855 | -8.8% | 1,131,088 | +1.0% | 0.02% | 0.0% |
Q2 2023 | $36,540,427 | -4.3% | 1,120,185 | +3.3% | 0.02% | -10.5% |
Q1 2023 | $38,168,633 | -24.7% | 1,084,644 | -1.9% | 0.02% | -26.9% |
Q4 2022 | $50,678,753 | -5.6% | 1,106,040 | -0.2% | 0.03% | -10.3% |
Q3 2022 | $53,696,000 | +25.0% | 1,108,272 | +1.3% | 0.03% | +38.1% |
Q2 2022 | $42,966,000 | +6.9% | 1,093,580 | +0.2% | 0.02% | +31.2% |
Q1 2022 | $40,191,000 | -15.1% | 1,091,872 | +5.1% | 0.02% | -5.9% |
Q4 2021 | $47,361,000 | +32.5% | 1,039,073 | +3.9% | 0.02% | +30.8% |
Q3 2021 | $35,742,000 | – | 1,000,047 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |